← Back to Analyst Consensus 
TNXP Buy
Tonix Pharmaceuticals Holding Corp.
Current Price —
Implied Upside —
Analysts 10
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 9, 2026 (14 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Jun 25, 2026 | Raymond James | initiate | — → Strong Buy | — | 54% |
| May 4, 2026 | TD Cowen | initiate | — → Buy | — | 54% |
| Mar 20, 2025 | Noble Capital Markets | reiterate | Outperform → Outperform | $70 | 63% |
| Jul 22, 2024 | Alliance Global Partners | maintain | Buy → Buy | $11 | 41% |
| Feb 28, 2024 | Dawson James | initiate | — → Buy | $3 | — |
| Aug 1, 2023 | Alliance Global Partners | maintain | Buy → Buy | $8 | 41% |
| Jun 2, 2023 | Alliance Global Partners | maintain | Buy → Buy | $18 | 41% |
| Aug 31, 2021 | Alliance Global Partners | maintain | Buy → Buy | $3 | 41% |
| Aug 11, 2021 | Alliance Global Partners | maintain | Buy → Buy | $2 | 41% |
| Feb 25, 2021 | Alliance Global Partners | maintain | Buy → Buy | $4 | 41% |
Price Target Trend
May 14, 2026 Latest: $44.25 Oct 25, 2026
EPS Estimates
0y $-9.82
Lo: $-10.15 Hi: $-9.50
2 analysts ▲1
+1y $-7.88
Lo: $-8.25 Hi: $-7.50
2 analysts ▲1
0q $-2.27
Lo: $-2.40 Hi: $-2.15
2 analysts ▲1
+1q $-2.29
Lo: $-2.48 Hi: $-2.10
2 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days